http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
울산지역 중소기업을 위한 관리시스템의 개발에 관한 연구
박혜규,김규년,구자록,이재동 울산대학교 1996 경영학연구논문집 Vol.3 No.2
본 논문에서는 울산지역 중소기업의 관리업무의 효율성을 제고시키는 관리시스템의 구축을 위하여 한 자동차 부품업체를 대상으로 부품의 수주, 생산, 납품, 수금 등을 관리하는 PC용 소프트웨어의 개발을 다룬다. 이 소프트웨어는 다수의 자동차 부품생산업체들에 있어서 공동으로 적용될 수 있으며 또한 대기업에 납품하는 협력업체가 많은 울산지역의 다른 중소기업들의 경우에도 적용될 수 있을 것이다. This paper deals with the design and development of managerial system suitable for small and medium-sized firms in Ulsan area. For this purpose, a PC-based software is developed for a company, one of subcontractors of Hyundai Motor Company (HMC) which are typical in Ulsan area. This software consists of the input, status, and change modules to deal with the information about orders of parts from HMC, delivery of parts just in the appointed time, and bill collecting. Though the software presented in this paper is developed for the company that manufactures auto parts, it can be used with minor adjustments for other small and medium-sized firms in Ulsan area.
약물요법으로 약물방출 스텐트 시술 후 재협착을 더 줄일 수 있나?
한규록 ( Kyoo Rok Han ) 대한내과학회 2008 대한내과학회지 Vol.74 No.4
Until now restenosis is one of the most important issues after stent implantation. Use of systemic drug therapy to inhibit post-stent restenosis has been largely unsuccessful. Drug-eluting stents (DES) have been shown to significantly reduce restenosis after percutaneous coronary intervention. However we still experience lots of problems associated with restenosis even after DES implantation. Recently some clinical trials have suggested that cilostazol reduces intimal hyperplasia and lowers restenosis after bare metal stents (BMS) implantation. It is uncertain that cilostazol can also reduce restenosis after DES implantation. We need more large clinical trials to elucidate the efficacy of cilostazol on restenosis after DES implantation.(Korean J Med 74:366-367, 2008)
인공삼첨판막의 혈전에 의한 삼첨판막 협착증의 임상상과 치료
한규록(Kyoo Rok Han),송종민(Jong Min Song),최성주(Sung Joo Choi),한기훈(Ki Hoon Han),박선수(Sun Soo Park),오병희(Byung Hee Oh),이명묵(Myoung Mook Lee),박영배(Young Bae Park),최윤식(Yun Shik Choi),서정돈(Jung Don Seo),노정일(Chung Il 대한내과학회 1994 대한내과학회지 Vol.46 No.4
N/A Background: Thrombosis of prosthetic valve occurs more frequently in the mechanical prosthetic valve than tissue valve and more frequently in right-side heart than left-side heart. This study shows the clinical characteristics and treatment of bileaflet prosthetic valve thrombosis in the tricuspid position. Methods: Patients with bileaflet prosthetic valve in tricuspid position were followed till clinically significant tricuspid stenosis due to thrombosis develops. Five patients had clinically significant thrombotic tricuspid stenosis. Diagnosis was based on history taking, physical examaination, echocardiograpy and cinefluoroscopy. Results: Anticoagulation therapy was inadequate in 4 of 5 patients. Prosthetic valve replacement was undertaken in one patient and four patients were treated with thrombolytic therapy using urokinase. Three patients among 4 patients managed with thrombolytic therapy were successfully treated. There was no serious complication. Cinefluoroscopy and echocardiography were useful in diagnosis and evaluation of the thrombolysis. Conclusions: Thrombolytic therapy is useful as an initial treatment of thrombosed tricuspid prosthetic valve stenosis without major complications.